You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood and bone marrow cancers

Selinexor with pomalidomide and dexamethasone for treating relapsed or refractory multiple myeloma after 1 to 4 treatment lines in people who have not had pomalidomide [ID6705]

  • Awaiting development
  • Reference number: GID-TA11938
  • Expected publication date: TBC
  • Project information
  • Project documents

33808-Selinexor-Pomalidomide-Dexamethasone-for-Multiple-Myeloma-V1.0-NOV2025-NON-CONF.pdf

Back to top